Now FDA approved for use in
adults with lung cancer

CYTALUX® is an optical imaging agent indicated as an adjunct for intraoperative identification of malignant lesions in adult patients with ovarian cancer and malignant and non-malignant pulmonary lesions in adult patients with known or suspected cancer in the lung.

View press release view prescribing information